Showing results (731-740 of 751) with videos related to

Sort By:
Pageof 76
Biorxiv : the Preprint Server for Biology|July 19, 2024
Sex-specific DNA methylation signatures of autism spectrum disorder in newborn bloodJulia S Mouat, Nickilou Y Krigbaum, Sophia Hakam, et al.
Polymers|May 27, 2026
Engineering Porous PET-RAFT Scaffolds with PLGA-Insulin Nanoparticles: Advancing Bone Tissue Regeneration Through Additive ManufacturingFernando E Rodríguez-Umanzor, Mauricio A Sarabia-Vallejos, Nicolás F Acuña-Ruiz, et al.
Biology of Sex Differences|April 30, 2025
Sex-specific DNA methylation signatures of autism spectrum disorder from whole genome bisulfite sequencing of newborn bloodJulia S Mouat, Nickilou Y Krigbaum, Sophia Hakam, et al.
American Journal of Human Genetics|April 14, 2009
Ciliary abnormalities due to defects in the retrograde transport protein DYNC2H1 in short-rib polydactyly syndromeAmy E Merrill, Barry Merriman, Claire Farrington-Rock, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2025
Decreased hippocampal neurite density in late-middle-aged adults following prenatal exposure to higher levels of maternal inflammationRaana A Mohyee, Blake L Elliott, Madeline R Pike, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Decreased hippocampal neurite density in late middle-aged adults following prenatal exposure to higher levels of maternal inflammationRaana A Mohyee, Blake L Elliott, Madeline R Pike, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2014
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II studyE Van Cutsem, C Boni, J Tabernero, et al.
Parasites & Vectors|February 10, 2012
Seroprevalence of Ehrlichia canis, Ehrlichia chaffeensis and Ehrlichia ewingii in dogs in North AmericaMelissa J Beall, A Rick Alleman, Ed B Breitschwerdt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinomaM H Voss, A Hussain, N Vogelzang, et al.
Pageof 76